Meningococcal disease as a model to evaluate novel anti-sepsis strategies

被引:7
作者
Cohen, J [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Infect Dis & Microbiol, London, England
关键词
meningococcemia; clinical trials; endotoxin; sepsis;
D O I
10.1097/00003246-200009001-00014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To consider the appropriateness of meningococcemia as a clinical entity for the evaluation of anti-endotoxin agents. Data Sources: English language published literature concerning meningococcemia, sepsis, and endotoxin, Study Selection: The purpose of this work is to consider some of the practical and scientific issues that arise in designing clinical trials to evaluate anti-endotoxin agents. A selected review of recently published articles was undertaken. Data Extraction and Synthesis: Relevant literature has been cited to support factual statements in the text. Conclusion: Meningococcemia as a paradigm of endotoxin-mediated Gram-negative sepsis has many advantages, It is a homogeneous population, and it represents a single, measurable, bacterial target that is unequivocally implicated in the pathogenesis of the disease. However, it is an uncommon disease that may develop so quickly that attempts to intervene may be too late to have an effect. There is considerable morbidity, hut how best to measure the outcome and the extent to which the results can be extrapolated to adult populations with sepsis secondary to nosocomial infection remain unclear.
引用
收藏
页码:S64 / S67
页数:4
相关论文
共 28 条
[1]   ENDOTOXIN LIBERATION FROM NEISSERIA MENINGITIDIS ISOLATED FROM CARRIERS AND CLINICAL CASES [J].
ANDERSEN, BM ;
SOLBERG, O ;
BRYN, K ;
FROHOLM, LO ;
GAUSTAD, P ;
HOIBY, EA ;
KRISTIANSEN, BE ;
BOVRE, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1987, 19 (04) :409-419
[2]   ENDOTOXIN RELEASE FROM INVASIVE MENINGOCOCCI RELATED TO SULFONAMIDE RESISTANCE, SEROGROUP AND SEROTYPE [J].
ANDERSEN, BM ;
SOLBERG, O ;
HOLTEN, E .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1987, 19 (01) :43-49
[3]   ENDOTOXIN LIBERATION ASSOCIATED WITH GROWTH, ENCAPSULATION AND VIRULENCE OF NEISSERIA MENINGITIDIS [J].
ANDERSEN, BM ;
SOLBERG, O .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (01) :21-31
[4]   Association of familial deficiency of mannose-binding lectin and meningococcal disease [J].
Bax, WA ;
Cluysenaer, OJJ ;
Bartelink, AKM ;
Aerts, PC ;
Ezekowitz, RAB ;
van Dijk, H .
LANCET, 1999, 354 (9184) :1094-1095
[5]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[6]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2, ALPHA-2-ANTIPLASMIN, PLASMINOGEN, AND ENDOTOXIN LEVELS IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
JOO, GB ;
BRUSLETTO, B ;
KIERULF, P .
THROMBOSIS RESEARCH, 1990, 57 (02) :271-278
[7]   PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
KIERULF, P ;
GAUSTAD, P ;
SKULBERG, A ;
BRUUN, JN ;
HALVORSEN, S ;
SORENSEN, E .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :195-204
[8]   COMPLEMENT ACTIVATION AND ENDOTOXIN LEVELS IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
MOLLNES, TE ;
KIERULF, P .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (01) :58-65
[9]   THE QUANTITATIVE ASSOCIATION OF PLASMA ENDOTOXIN, ANTITHROMBIN, PROTEIN-C, EXTRINSIC PATHWAY INHIBITOR AND FIBRINOPEPTIDE-A IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
SANDSET, PM ;
JOO, GB ;
OVSTEBO, R ;
ABILDGAARD, U ;
KIERULF, P .
THROMBOSIS RESEARCH, 1989, 55 (04) :459-470
[10]   Microbiologic findings and correlations with serum tumor necrosis factor-α in patients with severe sepsis and septic shock [J].
Cohen, J ;
Abraham, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :116-121